Page last updated: 2024-08-21

pyrazines and bsc2118

pyrazines has been researched along with bsc2118 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dai, Y; Doeppner, TR; Hermann, DM; Jin, F; Kuckelkorn, U; Li, F; Li, W; Li, X; Li, Z; Liu, L; Qiu, L; Zang, M; Zhou, W1

Other Studies

1 other study(ies) available for pyrazines and bsc2118

ArticleYear
Anti-tumor activity of the proteasome inhibitor BSc2118 against human multiple myeloma.
    Cancer letters, 2015, Oct-01, Volume: 366, Issue:2

    Topics: Animals; Antineoplastic Agents; Boronic Acids; Bortezomib; Butanes; Caspases; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Enzyme Activation; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Multiple Myeloma; Neovascularization, Pathologic; NF-kappa B; Oligopeptides; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Tumor Suppressor Protein p53; Up-Regulation; Xenograft Model Antitumor Assays

2015